GlassScriptPhysician profile
Kevin Thomas Lutz
NPI 1578562765
$1,089.57
in general payments reported to CMS, 2019-2025
13 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2021: $25.70 · 2022: $35.30 · 2023: $353 · 2024: $351 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $314.66 | 2023-2024 | Quviviq |
| Amgen INC. | $180.27 | 2021-2025 | Repatha, Otezla, Repatha |
| Viiv Healthcare Company | $168.67 | 2023-2025 | Cabenuva, Apretude |
| Allergan, INC. | $109.27 | 2019 | |
| Boston Scientific Corporation | $67.00 | 2019 | |
| Lilly USA, LLC | $58.98 | 2025 | Zepbound, Mounjaro, Kisunla |
| Inogen, INC. | $58.20 | 2024 | |
| Novartis Pharmaceuticals Corporation | $37.46 | 2022-2023 | |
| Inspire Medical Systems, INC. | $25.15 | 2023 | Inspire |
| Corcept Therapeutics | $20.87 | 2023 | Korlym |
| Glaxosmithkline, LLC. | $19.07 | 2023 | Arexvy, Shingrix |
| Lucid Diagnostics INC. | $15.13 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.